Celldex Therapeutics, Inc. (CLDX) SEC filings
CLDX SEC filings moved a median of +0.27% by the close. CLDX SEC filings — 10-K, 10-Q, 8-K and the rest — each read against the price at its own news timestamp. Back to the CLDX overview →
44 measured CLDX SEC filing events.
Where these CLDX SEC filings landedvs 44 measured CLDX SEC filing reactions
| Middle 50% of CLDX SEC filing reactions | -2.82% to +2.92% |
|---|---|
| Median reaction (to close) | +0.27% |
| Measured reactions | 44 |
Point-in-time · zero look-ahead
Half of the 44 CLDX SEC filing events with a measured close landed between -2.82% and +2.92%; 52% closed up.
| Date | Headline | Event | 5-min | To close |
|---|---|---|---|---|
| Form 8-K Celldex Therapeutics, For: Sep 22 | SEC filing · Form 8-K | +1.56% | -8.44% | |
| Form 10-Q Celldex Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.85% | -0.38% | |
| Form 8-K Celldex Therapeutics, For: Aug 06 | SEC filing · Form 8-K | +0.85% | -0.38% | |
| Form 8-K Celldex Therapeutics, For: Jul 10 | SEC filing · Form 8-K | -1.04% | -5.58% | |
| Form 8-K Celldex Therapeutics, For: Jun 25 | SEC filing · Form 8-K | +0.53% | +3.52% | |
| Form S-8 Celldex Therapeutics, | SEC filing · Form S-8 | +1.10% | +6.00% | |
| Form 10-Q Celldex Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | -3.38% | -2.78% | |
| Form 8-K Celldex Therapeutics, For: May 07 | SEC filing · Form 8-K | -3.38% | -2.78% | |
| Form ARS Celldex Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.95% | -1.80% | |
| Form DEF 14A Celldex Therapeutics, For: Jun 25 | SEC filing · Form DEF | +0.95% | -1.80% | |
| Form 8-K Celldex Therapeutics, For: Apr 01 | SEC filing · Form 8-K | -0.92% | +5.97% | |
| Form 10-K Celldex Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +0.39% | -0.74% | |
| Form 8-K Celldex Therapeutics, For: Feb 25 | SEC filing · Form 8-K | +0.39% | -0.74% | |
| Form 10-Q Celldex Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +1.84% | +9.58% | |
| Form 8-K Celldex Therapeutics, For: Nov 10 | SEC filing · Form 8-K | +1.84% | +9.58% | |
| Form 8-K Celldex Therapeutics, For: Aug 19 | SEC filing · Form 8-K | +2.66% | -4.87% | |
| Form 10-Q Celldex Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +4.19% | +1.92% | |
| Form 8-K Celldex Therapeutics, For: Aug 07 | SEC filing · Form 8-K | +4.19% | +1.92% | |
| Form 8-K Celldex Therapeutics, For: Jun 05 | SEC filing · Form 8-K | +0.65% | +7.45% | |
| Form S-8 Celldex Therapeutics, | SEC filing · Form S-8 | -1.24% | -5.13% | |
| Form 10-Q Celldex Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +7.25% | +0.71% | |
| Form 8-K Celldex Therapeutics, For: May 08 | SEC filing · Form 8-K | +7.25% | +0.71% | |
| Form ARS Celldex Therapeutics, For: Dec 31 | SEC filing · Form ARS | -0.47% | +1.25% | |
| Form DEF 14A Celldex Therapeutics, For: Jun 05 | SEC filing · Form DEF | -0.08% | +4.82% | |
| Form 10-K Celldex Therapeutics, For: Dec 31 | SEC filing · Form 10-K | -0.38% | +3.37% | |
| Form 8-K Celldex Therapeutics, For: Feb 27 | SEC filing · Form 8-K | -0.38% | +3.37% | |
| Form 10-Q Celldex Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | -0.21% | -5.46% | |
| Form 8-K Celldex Therapeutics, For: Nov 06 | SEC filing · Form 8-K | -0.21% | -5.46% | |
| Form 10-Q Celldex Therapeutics, For: Jun 30 | SEC filing · Form 10-Q | +0.40% | +0.27% | |
| Form 8-K Celldex Therapeutics, For: Aug 08 | SEC filing · Form 8-K | +0.40% | +0.27% | |
| Form 8-K Celldex Therapeutics, For: Jun 13 | SEC filing · Form 8-K | -0.41% | -2.94% | |
| Form S-8 Celldex Therapeutics, | SEC filing · Form S-8 | +0.12% | +1.19% | |
| Form 10-Q Celldex Therapeutics, For: Mar 31 | SEC filing · Form 10-Q | +1.10% | +2.78% | |
| Form 8-K Celldex Therapeutics, For: May 06 | SEC filing · Form 8-K | +1.10% | +2.78% | |
| Form ARS Celldex Therapeutics, For: Dec 31 | SEC filing · Form ARS | +0.39% | -0.03% | |
| Form DEF 14A Celldex Therapeutics, For: Jun 13 | SEC filing · Form DEF | -0.58% | -0.08% | |
| Form 8-K Celldex Therapeutics, For: Feb 28 | SEC filing · Form 8-K | -1.72% | -4.50% | |
| Form 10-K Celldex Therapeutics, For: Dec 31 | SEC filing · Form 10-K | +4.12% | +22.97% | |
| Form 8-K Celldex Therapeutics, For: Feb 26 | SEC filing · Form 8-K | +4.12% | +22.97% | |
| Form 8-K Celldex Therapeutics, For: Nov 07 | SEC filing · Form 8-K | +0.19% | -3.30% | |
| Form 8-K Celldex Therapeutics, For: Nov 05 | SEC filing · Form 8-K | -1.88% | -11.01% | |
| Form S-3ASR Celldex Therapeutics, | SEC filing · Form S-3ASR | -1.88% | -11.01% | |
| Form 10-Q Celldex Therapeutics, For: Sep 30 | SEC filing · Form 10-Q | +0.00% | +2.28% | |
| Form 8-K Celldex Therapeutics, For: Nov 02 | SEC filing · Form 8-K | +0.00% | +2.28% |
Keep exploring
More CLDX: earnings → · analyst actions → · CLDX overview →
Other Healthcare names and their SEC filings
| Ticker | Events | Median 30-min | % positive |
|---|---|---|---|
| SELLAS Life Sciences Group, Inc. (SLS) | 257 | -0.63% | 42% |
| Addus HomeCare Corporation (ADUS) | 256 | -0.02% | 47% |
| Prothena Corporation plc - Ordinary Shares (PRTA) | 256 | -0.04% | 49% |
| Xeris Biopharma Holdings, Inc. (XERS) | 256 | +0.32% | 57% |
Same sector, same measurement: percent move vs. the price at the news timestamp, read at 30 minutes. Sample sizes differ, so the medians are comparable but the confidence behind them is not. These are each name’s all-news baseline, not its SEC filings — that is what the link opens.